what was the first glp 1 agonist glp-1_analogs [TUSOM Emerging Frontiers in GLP-1 Therapeutics:

Now, Let's Unpack GLP-1 Agonists This is where things take a sharp turn into a completely different biological landscape

Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimers disease

Its prevalence has risen exponentially with the COVID-19 pandemic

Cardiovascular disease(CVD) is prevalent among people with diabetes

This review synthesizes current evidence linking microbiota alterations to Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and strokeincluding post-stroke cognitive impairment (PSCI), as well as major depressive disorder (MDD), bipolar disorder (BD), anxiety disorders, post-traumatic stress disorder (PTSD), and chronic fatigue syndrome (CFS)